Poseida Therapeutics OverviewPoseida Therapeutics Other Income Expense Net
Other Income/Expense Net for PSTX.
Quarterly Other Income/Expense
$536000.00
↓ 88.22% YoY
As of Sep 30, 2024
Annual Other Income/Expense (TTM)
$1.79M
↓ 76.98% YoY
Trailing 12 months ending Sep 30, 2024